506U78 in Treating Patients With Chronic Lymphocytic Leukemia That Has Not Responded to Fludarabine or Alkylating Agents

Completed · Phase 2

Conditions studied: Leukemia

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of 506U78 in treating patients with chronic lymphocytic leukemia that has not responded to fludarabine or alkylating agents.

Key facts

Study ID

NCT00003635

Run by

GlaxoSmithKline

Starts

1999-01-01

Expected to finish

2004-03-01

Last updated by the study team

2013-07-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Alabama at Birmingham Comprehensive Cancer Center — Birmingham, Alabama, United States
• Arizona Cancer Center — Tucson, Arizona, United States
• University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States
• Scripps Clinic — La Jolla, California, United States
• Cedars-Sinai Medical Center — Los Angeles, California, United States
• Jonsson Comprehensive Cancer Center, UCLA — Los Angeles, California, United States
• Sidney Kimmel Cancer Center — San Diego, California, United States
• Clinical Studies, Ltd. — Denver, Colorado, United States
• Lombardi Cancer Center — Washington D.C., District of Columbia, United States
• Walter Reed Army Medical Center — Washington D.C., District of Columbia, United States
• Robert H. Lurie Comprehensive Cancer Center, Northwestern University — Chicago, Illinois, United States
• University of Chicago Cancer Research Center — Chicago, Illinois, United States
• Holden Comprehensive Cancer Center at The University of Iowa — Iowa City, Iowa, United States
• Johns Hopkins Oncology Center — Baltimore, Maryland, United States
• Medicine Branch — Bethesda, Maryland, United States
• Washington University School of Medicine — St Louis, Missouri, United States
• St. Joseph's Hospital and Medical Center — Paterson, New Jersey, United States
• Long Island Jewish Medical Center — New Hyde Park, New York, United States
• Ireland Cancer Center — Cleveland, Ohio, United States
• Greenville Hospital System — Greenville, South Carolina, United States
• Physician Reliance Network, Inc. — Dallas, Texas, United States
• University of Texas - MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.